X0306 4 2019-01-28 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001725922 Shah Gaurav C/O ROCKET PHARMACEUTICALS, INC. 350 FIFTH AVENUE, SUITE 7530 NEW YORK NY 10118 true true See Remarks Stock Option (Right to Buy) 14.56 2019-01-28 4 A 0 315700 0 A 2029-01-28 Common Stock 315700 315700 D This option represents a right to purchase a total of 315,700 shares of the Issuer's Common Stock, 105,236 of which will become fully vested and exercisable on January 28, 2020, with the remaining 210,464 shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. President and Chief Executive Officer Exhibit 24 - Power of Attorney /s/ Sara Turken, as attorney-in-fact for Gaurav Shah 2019-01-30